Michelle Pek
About Michelle Pek
Michelle Pek is a Medical Data Scientist with a background in Biological Sciences and Cancer Biology. She has contributed to significant research in multi-cancer early detection assays and screening tests, publishing in prominent medical journals.
Work at Lucence Health
Michelle Pek has been employed at Lucence since 2018, serving as a Medical Data Scientist. In this role, she focuses on the analysis and interpretation of medical data, contributing to advancements in cancer detection and treatment methodologies. Her work supports the development of innovative diagnostic tools that leverage genomic data to improve patient outcomes.
Education and Expertise
Michelle Pek holds a Bachelor of Science with Honours in Biological Sciences from Nanyang Technological University Singapore, where she studied from 2007 to 2011. She furthered her education at the National University of Singapore, earning a Doctor of Philosophy in Cancer Biology between 2012 and 2016. Her academic background provides a strong foundation in biological sciences and cancer research.
Background
Michelle Pek's academic journey began at Nanyang Technological University Singapore, where she completed her undergraduate studies. Following her undergraduate education, she pursued a PhD in Cancer Biology at the National University of Singapore. This educational path has equipped her with extensive knowledge in the field of oncology and medical data analysis.
Achievements in Research
In 2023, Michelle Pek co-authored two significant publications. One was in the Annals of Oncology, focusing on a circulating tumor DNA mutation-based multi-cancer early detection assay. The other publication appeared in the Journal of Clinical Oncology, detailing the development and evaluation of a multi-cancer screening test tailored for cancers prevalent in Asia. These contributions reflect her active involvement in advancing cancer research.